Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma

Background The high postoperative recurrence rate of hepatocellular carcinoma (HCC) is a significant challenge. Patient metabolic factors are potential disease modifiers and should be examined as risk factors for postoperative prognosis. Here, we assessed the association between long‐term statin use...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation 2023-04, Vol.53 (4), p.e13936-n/a
Hauptverfasser:	Yun, Byungyoon, Ahn, Sang Hoon, Oh, Juyeon, Yoon, Jin‐Ha, Kim, Beom Kyung
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery Carcinoma, Hepatocellular - virology chronic hepatitis B Female HCC Hepatitis Hepatitis B Hepatitis B virus Hepatocellular carcinoma Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Liver Liver cancer Liver Neoplasms - drug therapy Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - surgery Liver Neoplasms - virology Male Middle Aged Mortality Neoplasm Recurrence, Local - epidemiology Prognosis Rank tests recurrence Regression analysis Risk Assessment Risk factors Risk management statin Statins Statistical analysis surgical resection User groups Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!